In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, Amazon Music, or wherever you get your podcasts!
In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so. Hear how APs can leverage their deep role in the day-to-day cancer care decisions to improve diversity in clinical trials by bringing their experience to trial design and the accrual process.
“We deal with the side effects of treatment. We know how to identify... and manage adverse events. So in the realm of clinical research, it just makes a ton sense for us to be managing patients on trial.”
Christa Braun-Inglis, MS, APRN, FNP-BC, AONP
Nurse Practitioner and Clinical Researcher
University of Hawaii Cancer Center
Honolulu, Hawaii
This mini-podcast—and two additional shows—will share key themes from the Summit. Look for more findings coming soon to the ACCC website.
Thank you to Pfizer Oncology for their collaboration and support in hosting the ACCC-Harborside Virtual Summit.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
